2 results
Approved WMOCompleted
To determine whether treatment with RAD001 10 mg/d plus Sandostatin LARĀ® prolongs the progression free survival (PFS) compared to treatment with Sandostatin LARĀ® alone in patients with advanced carcinoid tumor.
Approved WMOCompleted
To measure the effectiveness of intrathecal methylprednisolone and lidocaine on reducing PHN. Measurement of mthylprednisolone concentrations in cerebrospinal fluid (Part I only).